{
    "title": "Bluebird bio's blood disorder therapy effective - FDA staff",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10893201/Bluebird-bios-blood-disorder-therapy-effective--FDA-staff.html",
    "date": "2022-06-07",
    "keywords": [
        "gene",
        "company",
        "therapy",
        "treatment",
        "approval",
        "roy",
        "blood",
        "staff",
        "beticel",
        "year",
        "bluebird",
        "panel",
        "june",
        "disorder",
        "benefit",
        "food",
        "drug",
        "administration",
        "betathalassemia",
        "effectiveness",
        "httpswwwfdagovmedia159009download",
        "companys",
        "stock",
        "httpswwwfdagovmedia159010download",
        "elicel",
        "disease",
        "adrenoleukodystrophy",
        "safety",
        "longterm",
        "risk",
        "syndrome",
        "agency",
        "program",
        "hold",
        "trial",
        "type",
        "cancer",
        "causal",
        "relationship",
        "tuesday",
        "followup",
        "response",
        "totality",
        "case",
        "week",
        "moment",
        "time",
        "tissue",
        "committee",
        "spark",
        "outcome",
        "march",
        "concern",
        "position",
        "cash",
        "runwaythe",
        "decision",
        "space",
        "pivotal",
        "analyst",
        "raju",
        "prasad",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}